Interestingly, kynurenine has also been shown to induce depression-like behavior, and pharmacological inhibition of IDO blocks microglial activation and the development of depression-like behavior (O’Connor et al. 2009). This evidence concerns the gene IDO1 and depressive symptom measurement.